Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

KOS

Kosmos Energy Ltd

Feb 17 • 10:37AM ET

1.56

-0.12 -7.14 %

Energy • Oil & Gas E&P • USA • NYSE

Peers: XOM HES CVX COP OXY APA DVN EOG MPC MUR

| Held by: IWM XOP FNDA FCG VXF IWN VDE FYX SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-0.69	Insider Own	4.11%	Shs Outstand	478.25M	Perf Week	0.65%
Market Cap	746.24M	Forward P/E	-	EPS next Y	-0.16	Insider Trans	-1.37%	Shs Float	458.69M	Perf Month	24.81%
Enterprise Value	3.66B	PEG	-	EPS next Q	-0.12	Inst Own	82.51%	Short Float	10.95%	Perf Quarter	8.34%
Income	-329.22M	P/S	0.53	EPS this Y	-243.37%	Inst Trans	-1.57%	Short Ratio	2.91	Perf Half Y	-8.23%
Sales	1.40B	P/B	0.83	EPS next Y	73.74%	ROA	-6.23%	Short Interest	50.24M	Perf YTD	71.93%
Book/sh	1.88	P/C	11.65	EPS next 5Y	-	ROE	-31.42%	52W High	3.49 -55.30%	Perf Year	-50.32%
Cash/sh	0.13	P/FCF	-	EPS past 3/5Y	- -	ROIC	-9.08%	52W Low	0.84 86.59%	Perf 3Y	-79.20%
Dividend Est.	-	EV/EBITDA	7.70	Sales past 3/5Y	7.85% 2.32%	Gross Margin	-1.28%	Volatility	10.34% 9.71%	Perf 5Y	-46.57%
Dividend TTM	-	EV/Sales	2.61	EPS Y/Y TTM	-248.33%	Oper. Margin	-7.24%	ATR (14)	0.15	Perf 10Y	-63.29%
Dividend Ex-Date	Mar 04, 2020	Quick Ratio	0.29	Sales Y/Y TTM	-22.11%	Profit Margin	-23.52%	RSI (14)	55.24	Recom	2.27
Dividend Gr. 3/5Y	- -	Current Ratio	0.52	EPS Q/Q	-377.08%	SMA20	6.06%	Beta	0.83	Target Price	2.40
Payout	0.00%	Debt/Eq	3.31	Sales Q/Q	-24.38%	SMA50	30.64%	Rel Volume	0.91	Prev Close	1.68
Employees	243	LT Debt/Eq	3.04	Earnings	Mar 02 BMO	SMA200	-2.71%	Avg Volume	17.26M	Price	1.56
IPO	May 11, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	-21.85% -9.34%	Trades		Volume	3,358,554	Change	-7.14%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-25	Downgrade	Johnson Rice	Buy → Accumulate	$3.50
Dec-05-25	Downgrade	BofA Securities	Buy → Underperform	$1
Nov-11-25	Initiated	Stephens	Equal-Weight	$1.75
Oct-24-25	Initiated	Clarksons Platou	Buy	$4
Sep-22-25	Downgrade	Goldman	Buy → Neutral	$2
Mar-04-25	Downgrade	The Benchmark Company	Buy → Hold
Dec-18-24	Resumed	Jefferies	Buy	$5.60
Sep-19-24	Initiated	Mizuho	Neutral	$5
Nov-20-23	Initiated	Stifel	Buy	$10
Oct-17-23	Downgrade	Bernstein	Outperform → Mkt Perform	$12 → $9
Sep-27-23	Upgrade	BofA Securities	Neutral → Buy	$8.70 → $10
Jul-20-23	Initiated	Redburn	Buy	$9
Mar-10-23	Initiated	Peel Hunt	Add	$8.94
Feb-28-23	Downgrade	BofA Securities	Buy → Neutral	$10 → $9.60
Feb-09-23	Initiated	The Benchmark Company	Buy	$10
Aug-25-22	Upgrade	Berenberg	Hold → Buy	$8.30 → $8.50
Jun-13-22	Downgrade	Berenberg	Buy → Hold
Nov-11-21	Upgrade	Barclays	Equal Weight → Overweight	$3.95
Oct-15-21	Upgrade	Berenberg	Hold → Buy
Jun-21-21	Upgrade	Bernstein	Mkt Perform → Outperform

Show Previous Ratings

Feb-02-26 02:00AM	Kosmos Energy to Host Fourth Quarter 2025 Results and Webcast on March2, 2026 (Business Wire) -13.92%
Jan-17-26 12:09AM	Kosmos Energy (KOS) Shot Up This Week. Here is Why (Insider Monkey)
Jan-16-26 10:05AM	Kosmos Energy Announces Pricing of Nordic Bond Issue (Business Wire)
Jan-12-26 04:23AM	Kosmos Energy (KOS) Shares Operational Update, Bernstein Remains Bullish (Insider Monkey) +10.35%
02:00AM	Kosmos Energy Announces Launch of Nordic Bond Issue and Cash Tender Offer for 7.750% Senior Notes Due 2027 (Business Wire)
12:12AM	Loading…
Jan-08-26 12:12AM	Kosmos Energy (KOS) Gains Following Significant Progress in West Africa (Insider Monkey)
Jan-05-26 02:00AM	Kosmos Energy Provides Operational and Financial Update (Business Wire) +10.89%
Dec-20-25 06:47AM	Kosmos Energy (KOS) Price Targets Trimmed by Analysts (Insider Monkey)
Dec-09-25 11:49AM	Kosmos Energy (KOS) Misses Q3 Estimates, Analysts Split on Outlook (Insider Monkey)
Dec-05-25 09:42AM	CoreWeave initiated, Unity upgraded: Wall Street's top analyst calls (The Fly) +7.48%
Nov-24-25 06:30AM	Tullow Oil moves forward on Ghana licence extensions and gas agreement (Offshore Technology)
Nov-11-25 09:06AM	Here are Tuesdays Top Wall Street Analyst Research Calls: Coreweave, Instacart, Qorvo, Robinhood Markets, Skyworks Solutions, Viasat and More (24/7 Wall St.)
Nov-03-25 06:02PM	Kosmos Energy Ltd (KOS) Q3 2025 Earnings Call Highlights: Strong Production Growth and ... (GuruFocus.com) -5.73%
05:10AM	Kosmos Energy: Q3 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces Third Quarter 2025 Results (Business Wire)
01:46AM	Loading…
Oct-28-25 01:46AM	Kosmos Energy (KOS) - Among the Energy Stocks that Gained This Week (Insider Monkey)
Oct-15-25 07:16AM	Kosmos Energy Ltd. (KOS) Finishes Its Semi-Annual Assessment of Reserve-Based Lending Facilities (Insider Monkey)
Oct-07-25 02:00AM	Kosmos Energy to Host Third Quarter 2025 Results and Webcast on November 03, 2025 (Business Wire)
Oct-01-25 02:00AM	Kosmos Energy Provides Update on Financial Progress (Business Wire)
Sep-25-25 08:00AM	Kosmos Energy Enters Into Senior Secured Term Loan Facility With Shell for up to $250 Million (Business Wire)
Aug-25-25 07:44AM	3 Energy Stocks Under $5 With Strong Value Fundamentals (Zacks)
Aug-22-25 11:45PM	Bank of America Securities Lowers PT on Kosmos Energy (KOS), Maintains a Buy Rating (Insider Monkey) +5.75%
Aug-19-25 12:32AM	Kosmos Energy Ltd. (KOS) Reports Q2 2025 Results; Bank of America Reiterates 'Hold' Rating (Insider Monkey) -5.71%
Aug-05-25 02:30AM	Kosmos Posts $88 Million Q2 Loss Amid Ramp-Up of West Africa LNG Project (Oilprice.com)
Aug-04-25 05:07AM	Kosmos Energy: Q2 Earnings Snapshot (Associated Press Finance)
03:27AM	Kosmos Energy Q2 loss wider than expected, full-year outlook lowered (Investing.com)
02:00AM	Kosmos Energy Announces Second Quarter 2025 Results (Business Wire)
Jul-31-25 12:21AM	S&P Downgrades Kosmos Energy to 'CCC+' Amid Liquidity Strains and Refinancing Risks (Insider Monkey)
Jul-30-25 10:15AM	Kosmos Energy Ltd. (KOS) Fell Due to Market Concerns Amid OPEC+ Supply and Demand Fears (Insider Monkey) -5.17%
Jul-29-25 09:35AM	Kosmos Energy (KOS) Soars 7.7% Ahead of Q2 Earnings (Insider Monkey)
09:40AM	Loading…
Jul-21-25 09:40AM	Should Value Investors Buy Kosmos Energy (KOS) Stock? (Zacks)
Jul-18-25 08:05AM	Kosmos Energy (KOS) Fell Along with Broader Energy Prices (Insider Monkey)
Jul-17-25 12:55PM	Domestic Drillers Rush To Power AI Grid As Global Oil Demand Stays Unbroken (PR Newswire) +7.33%
Jul-08-25 02:00AM	Kosmos Energy to Host Second Quarter 2025 Results and Webcast on August 04, 2025 (Business Wire) +6.47%
Jul-07-25 09:10AM	Jefferies Maintains a Buy on Kosmos Energy (KOS) (Insider Monkey)
Jun-24-25 06:09AM	FLNG Gimi starts commercial operations at Greater Tortue Ahmeyim project (Offshore Technology)
Jun-23-25 06:49AM	Kosmos Energy Confirms Commercial Operations Date Reached for Golars FLNG Gimi at Greater Tortue Ahmeyim (Business Wire) -7.83%
Jun-13-25 03:32AM	Kosmos Energy (KOS): Among the Energy Stocks that Gained the Most This Week (Insider Monkey) +7.66%
Jun-04-25 02:00AM	The Government of Ghana, Tullow Oil, Kosmos Energy, PetroSA, GNPC and Explorco Sign Memorandum of Understanding to Extend Ghana Production Licenses to 2040 (Business Wire)
May-21-25 02:56AM	Why Did Kosmos Energy (KOS) Fall So Much This Week? (Insider Monkey)
May-19-25 11:04AM	Here's How the Short-Term Issues are Affecting Kosmos Energy Ltd.'s (KOS) (Insider Monkey)
May-15-25 03:47PM	Here is Why Kosmos Energy Ltd. (KOS) Surged So High This Week (Insider Monkey) -12.06%
May-07-25 03:18AM	Kosmos Energy Ltd (KOS) Q1 2025 Earnings Call Highlights: Strategic Cost Control and Production ... (GuruFocus.com)
02:06AM	Q1 2025 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
May-06-25 05:07AM	Kosmos Energy: Q1 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces First Quarter 2025 Results (Business Wire)
Apr-26-25 10:17AM	Is Kosmos Energy Ltd. (KOS) the Best Oil and Gas Penny Stock to Invest in Now? (Insider Monkey)
Apr-22-25 12:00PM	Patient Capital Management Q1 2025 Investment Review (Seeking Alpha)
Apr-17-25 02:54PM	BP, Kosmos Loads First LNG Export From GTA Phase 1, One of Africa's Deepest Gas Projects (Benzinga) +7.83%
02:31AM	Kosmos Energy Announces First LNG Cargo at the Greater Tortue Ahmeyim Project in Mauritania and Senegal (Business Wire)
Apr-07-25 02:00AM	Kosmos Energy to Host First Quarter 2025 Results and Webcast on May 6, 2025 (Business Wire) +12.50%
Apr-05-25 01:45PM	Why Kosmos Energy Ltd. (KOS) Stock Crashed This Week (Insider Monkey)
Mar-31-25 09:28AM	Should You Hold Kosmos Energy Ltd. (KOS)? (Insider Monkey)
Mar-26-25 02:14PM	Is Kosmos Energy Ltd. (KOS) the Best Fundamentally Strong Penny Stock to Buy Now? (InsiderMonkey)
Mar-25-25 05:42PM	Is Kosmos Energy Ltd. (NYSE:KOS) The Top Penny Stock That Will Skyrocket? (InsiderMonkey)
Mar-19-25 03:29AM	Is Kosmos Energy (KOS) One of the Most Oversold Penny Stocks to Buy According to Analysts? (Insider Monkey)
Mar-13-25 05:55PM	Why Kosmos Energy Ltd. (KOS) Is Losing This Week? (Insider Monkey)
Mar-08-25 09:14PM	Kosmos Energy Ltd. (KOS): Among the Best NYSE Penny Stocks to Buy According to Analysts (Insider Monkey)
Mar-05-25 06:30PM	Kosmos Energy Ltd. (KOS): Among the Best Value Penny Stocks to Invest In Now (Insider Monkey) -7.39%
Feb-27-25 11:05AM	Why Kosmos Energy (KOS) Is Losing this Week? (Insider Monkey) +5.28%
Feb-25-25 05:24AM	BP, Kosmos Greater Tortue Ahmeyim project prepares for first LNG shipment (Offshore Technology) -7.64%
02:02AM	Kosmos Energy Ltd (KOS) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... (GuruFocus.com)
01:57AM	Q4 2024 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
Feb-24-25 06:07AM	Is Kosmos Energy Ltd. (KOS) the Best Get Rich Quick Stock to Invest In? (Insider Monkey) -9.43%
05:13AM	Kosmos Energy: Q4 Earnings Snapshot (Associated Press Finance)
03:37AM	BPs Greater Tortue Project Poised to Export First LNG Cargo (Bloomberg)
02:00AM	Kosmos Energy Announces Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-20-25 10:38AM	Is Kosmos Energy Ltd. (KOS) the Best Get Rich Fast Stock to Buy Now? (Insider Monkey)
Feb-10-25 11:05AM	Kosmos Energy achieves first LNG production at greater Tortue Ahmeyim project (Offshore Technology) +7.97%
02:00AM	Kosmos Energy Announces First LNG at the Greater Tortue Ahmeyim Project in Mauritania and Senegal (Business Wire)
Jan-22-25 07:08PM	Is Kosmos Energy (KOS) Among the Worst Performing Energy Stocks in 2024? (Insider Monkey)
Jan-20-25 09:59PM	Kosmos Energy Ltd. (KOS) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-13-25 02:00AM	Kosmos Energy to Host Fourth Quarter 2024 Results and Webcast on February 24, 2025 (Business Wire)
Jan-03-25 10:00AM	How to Navigate the Stock and Bond Markets in 2025 (The Wall Street Journal)
Jan-02-25 02:02AM	Kosmos Energy Announces First Gas at the Greater Tortue Ahmeyim LNG Project in Mauritania and Senegal (Business Wire) +8.77%
Dec-26-24 09:19AM	Kosmos (KOS) Stock was Pressured As Oil Prices Continued To Decline (Insider Monkey)
Dec-18-24 05:21AM	Kosmos Energy withdraws from Tullow Oil acquisition (Offshore Technology)
Dec-17-24 12:45PM	Form 8.3 - Kosmos Energy Ltd. (Business Wire) +19.19%
05:30AM	Kosmos Energy Statement Regarding Possible Offer for Tullow Oil plc (Business Wire)
Dec-12-24 03:04PM	Statement Regarding a Possible All-Share Offer for Tullow Oil plc by Kosmos Energy Ltd. (Business Wire) -15.09%
Nov-12-24 09:40AM	Are Investors Undervaluing Kosmos Energy (KOS) Right Now? (Zacks)
Nov-07-24 04:36AM	Senegal Expects First LNG Shipment Early Next Year (Bloomberg)
Nov-06-24 03:06PM	Is Kosmos Energy Ltd. (KOS) Positioned for Growth in the Oversold Energy Sector? (Insider Monkey)
12:51AM	Kosmos Energy Ltd. (KOS): Top Penny Stock with Growth Potential (Insider Monkey)
Nov-05-24 02:49AM	Q3 2024 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
02:05AM	Kosmos Energy Ltd (KOS) Q3 2024 Earnings Call Highlights: Production Gains and Financial Resilience (GuruFocus.com)
Nov-04-24 05:02AM	Kosmos Energy: Q3 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces Third Quarter 2024 Results (Business Wire)
Nov-03-24 12:14PM	Kosmos Energy Ltd. (KOS): Oversold Penny Stock To Invest In Now (Insider Monkey)
Oct-29-24 09:24AM	Kosmos Energy Ltd. (KOS): Oversold Small Cap Stock with Promising Growth Projects (Insider Monkey)
Oct-20-24 06:59PM	Is Kosmos Energy Ltd. (KOS) the Best Affordable Stock Under $10 to Buy? (Insider Monkey)
Oct-19-24 04:58PM	Kosmos Energy Ends Revolving Credit Facility Agreement (TipRanks)
Oct-18-24 08:02AM	Heres Why Patient Capital Management Saw Kosmos Energy (KOS) as a Classic Case Of Time Arbitrage (Insider Monkey)
Oct-16-24 07:16PM	Is Kosmos Energy Ltd. (KOS) the Most Promising Stock to Buy According to Wall Street Analysts? (Insider Monkey)
10:57AM	Is Kosmos Energy Ltd. (KOS) the Best High Growth Penny Stock That is Profitable in 2024? (Insider Monkey)
Oct-12-24 12:26PM	Is Kosmos Energy Ltd. (KOS) the Best Growth Stock Under $10 to Buy? (Insider Monkey)
Oct-09-24 07:34AM	BP wins arbitration against Kosmos for GTA LNG project (Offshore Technology)
Oct-08-24 12:50PM	Arbitration rules in favour of BP as sole buyer of Kosmos Energy's Senegal LNG project (Reuters)
Oct-03-24 02:00AM	Kosmos Energy to Host Third Quarter 2024 Results and Webcast on November 04, 2024 (Business Wire) +5.62%
Oct-01-24 11:00AM	Hedge Fund Interest in Kosmos Energy Ltd. (KOS) Stable at 25 Holders in Q2 2024 (Insider Monkey) +5.71%

Kosmos Energy Ltd. engages in the exploration, development, and production of oil and gas. The firm's assets include production offshore Ghana, Equatorial Guinea and the U.S. Gulf of Mexico, as well as a gas development offshore Mauritania and Senegal. It also maintains a sustainable exploration program balanced between proven basin infrastructure-led exploration, emerging basins, and frontier basins. The company was founded by Brian F. Maxted on April 23, 2003 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Glass Ronald W.	VP & Chief Accounting Officer	Feb 03 '26	Sale	1.37	19,285	26,420	342,945	Feb 05 05:13 PM
Glass Ronald W.	VP & Chief Accounting Officer	Feb 04 '26	Sale	1.42	3,313	4,704	339,632	Feb 05 05:13 PM
Marion Josh R.	SVP and General Counsel	Feb 03 '26	Sale	1.37	19,656	26,929	197,409	Feb 05 05:12 PM
Marion Josh R.	SVP and General Counsel	Feb 04 '26	Sale	1.42	3,284	4,663	194,125	Feb 05 05:12 PM
Shah Nealesh D.	SVP and CFO	Feb 03 '26	Sale	1.37	54,434	74,575	1,729,857	Feb 05 05:12 PM
Shah Nealesh D.	SVP and CFO	Feb 04 '26	Sale	1.42	24,690	35,060	1,705,167	Feb 05 05:12 PM
INGLIS ANDREW G	Chairman and CEO	Feb 03 '26	Sale	1.37	103,554	141,869	4,271,645	Feb 05 05:10 PM
INGLIS ANDREW G	Chairman and CEO	Feb 04 '26	Sale	1.42	44,628	63,372	4,227,017	Feb 05 05:10 PM
INGLIS ANDREW G	Officer	Feb 04 '26	Proposed Sale	1.42	44,628	63,452		Feb 04 03:27 PM
Shah Nealesh D.	Officer	Feb 04 '26	Proposed Sale	1.42	24,690	35,104		Feb 04 03:26 PM
Marion Josh R.	Officer	Feb 04 '26	Proposed Sale	1.42	3,284	4,669		Feb 04 03:16 PM
Glass Ronald W.	Officer	Feb 04 '26	Proposed Sale	1.42	3,313	4,710		Feb 04 03:08 PM
Marion Josh R.	Officer	Feb 03 '26	Proposed Sale	1.38	19,656	27,060		Feb 03 04:52 PM
Shah Nealesh D.	Officer	Feb 03 '26	Proposed Sale	1.38	54,434	74,939		Feb 03 04:34 PM
INGLIS ANDREW G	Officer	Feb 03 '26	Proposed Sale	1.38	103,554	142,563		Feb 03 04:27 PM
Glass Ronald W.	Officer	Feb 03 '26	Proposed Sale	1.38	19,285	26,550		Feb 03 04:21 PM
Christopher James Ball	Former Officer	Dec 18 '25	Proposed Sale	0.99	1,430,084	1,420,931		Dec 22 04:28 PM
Christopher James Ball	Former Officer	Dec 17 '25	Proposed Sale	0.92	7,787	7,163		Dec 18 04:33 PM
Grant John Douglas Kelso	Director	Jun 05 '25	Sale	1.81	27,923	50,541	29,921	Jun 06 04:53 PM
Grant John Douglas Kelso	Director	Jun 05 '25	Proposed Sale	1.81	27,923	50,541		Jun 05 10:02 AM

NBIX Neurocrine Biosciences, Inc daily Stock Chart

Peers: VRTX REGN BIIB GILD INCY ALNY EXEL IONS SAGE ACAD

| Held by: VTI IJH VB VBK VXF MDY IBB XBI FBT IWP

Index	-	P/E	27.44	EPS (ttm)	4.67	Insider Own	2.67%	Shs Outstand	100.10M	Perf Week	-8.21%
Market Cap	12.86B	Forward P/E	17.08	EPS next Y	7.50	Insider Trans	-3.64%	Shs Float	97.69M	Perf Month	-3.94%
Enterprise Value	11.85B	PEG	0.62	EPS next Q	1.11	Inst Own	98.90%	Short Float	3.42%	Perf Quarter	-11.15%
Income	478.60M	P/S	4.49	EPS this Y	26.04%	Inst Trans	1.70%	Short Ratio	3.03	Perf Half Y	-3.61%
Sales	2.86B	P/B	3.94	EPS next Y	27.45%	ROA	11.13%	Short Interest	3.34M	Perf YTD	-9.68%
Book/sh	32.50	P/C	8.68	EPS next 5Y	27.58%	ROE	16.38%	52W High	160.18 -20.03%	Perf Year	11.37%
Cash/sh	14.75	P/FCF	17.17	EPS past 3/5Y	44.05% 2.31%	ROIC	13.05%	52W Low	84.23 52.08%	Perf 3Y	23.72%
Dividend Est.	-	EV/EBITDA	17.77	Sales past 3/5Y	24.32% 22.29%	Gross Margin	98.18%	Volatility	4.38% 3.12%	Perf 5Y	11.11%
Dividend TTM	-	EV/Sales	4.14	EPS Y/Y TTM	41.73%	Oper. Margin	22.25%	ATR (14)	4.57	Perf 10Y	235.86%
Dividend Ex-Date	-	Quick Ratio	3.30	Sales Y/Y TTM	21.45%	Profit Margin	16.73%	RSI (14)	38.61	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	3.39	EPS Q/Q	47.94%	SMA20	-5.26%	Beta	0.33	Target Price	177.26
Payout	0.00%	Debt/Eq	0.14	Sales Q/Q	28.33%	SMA50	-8.81%	Rel Volume	0.91	Prev Close	124.12
Employees	2000	LT Debt/Eq	0.13	Earnings	Feb 11 AMC	SMA200	-5.62%	Avg Volume	1.10M	Price	128.10
IPO	May 23, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	-17.97% 1.90%	Trades		Volume	213,637	Change	3.20%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$175
Oct-21-25	Initiated	Citigroup	Buy	$175
Jul-21-25	Initiated	Truist	Buy	$163
Jul-10-25	Initiated	Goldman	Buy	$182
Apr-15-25	Upgrade	Needham	Hold → Buy	$138
Apr-14-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$137
Feb-11-25	Initiated	Deutsche Bank	Hold	$138
Oct-10-24	Resumed	Raymond James	Outperform	$155
Aug-29-24	Upgrade	Piper Sandler	Neutral → Overweight	$131 → $159
Apr-24-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$140 → $170
Dec-13-23	Resumed	Citigroup	Neutral	$127
Dec-12-23	Initiated	Deutsche Bank	Buy	$136
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight	$135 → $140
Aug-21-23	Reiterated	Mizuho	Neutral	$112 → $113
Jul-24-23	Upgrade	SVB Securities	Market Perform → Outperform	$115 → $125
Jul-06-23	Upgrade	BMO Capital Markets	Underperform → Market Perform	$91 → $96
May-04-23	Upgrade	Guggenheim	Neutral → Buy	$145
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy	$124 → $132
Mar-03-23	Upgrade	Evercore ISI	In-line → Outperform	$130
Feb-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$120 → $130

Show Previous Ratings

Feb-12-26 02:38PM	Analysts Stay Bullish As Neurocrine Shares Tumble On Disappointing Ingrezza Guidance (Benzinga) -10.43%
12:23PM	Earnings roundup: Neurocrine slumps, Alnylam battles skeptics and Ascendis eyes a competitor (BioPharma Dive)
08:30AM	Neurocrine Biosciences, Inc. Q4 2025 Earnings Call Summary (Moby)
12:04AM	Neurocrine Biosciences Inc (NBIX) Q4 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
Feb-11-26 06:39PM	Neurocrine Biosciences Q4 Earnings Call Highlights (MarketBeat)
05:30PM	Loading…
05:30PM	Neurocrine (NBIX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:10PM	Neurocrine Biosciences (NBIX) Lags Q4 Earnings Estimates (Zacks)
04:17PM	Neurocrine: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026 (PR Newswire)
Feb-06-26 09:15AM	Exploring Analyst Estimates for Neurocrine (NBIX) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-05-26 10:00AM	Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
09:29AM	Neurocrine Biosciences to Report Q4 Earnings: What's in the Cards? (Zacks)
08:10AM	Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-04-26 10:00AM	Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-26-26 08:30AM	Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia (PR Newswire)
12:10PM	Loading…
Jan-22-26 12:10PM	Can Neurocrine (NBIX) Keep the Earnings Surprise Streak Alive? (Zacks)
Jan-21-26 04:01PM	Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results (PR Newswire)
Jan-15-26 08:30AM	Neurocrine Biosciences Presents Head-to-Head INGREZZA (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR (PR Newswire)
Jan-08-26 04:10PM	How Eli Lilly's Plan To Buy Ventyx For $1.2 Billion Could Benefit Neumora, Neurocrine (Investor's Business Daily)
08:09AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Alphabet, Coinbase Global, Digital Realty Trust, Intuit, Reddit, Roku, Tyler Technologies, and More (24/7 Wall St.)
Jan-05-26 04:01PM	Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-25 04:05PM	Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy (PR Newswire)
Dec-16-25 04:01PM	Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology (PR Newswire)
Dec-09-25 04:01PM	Neurocrine Biosciences to Host R&D Day on December 16 (PR Newswire)
Dec-05-25 08:03AM	Leading Drug Stock Fights To Regain Buy Point At Key Resistance Level (Investor's Business Daily)
Nov-27-25 12:45PM	Here is Why Growth Investors Should Buy Neurocrine (NBIX) Now (Zacks)
Nov-26-25 04:11PM	Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied (Investor's Business Daily) +5.61%
Nov-20-25 08:30AM	Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA (valbenazine) Capsules (PR Newswire)
Nov-11-25 04:01PM	Neurocrine Biosciences to Present at Upcoming Investor Conferences (PR Newswire)
12:45PM	Looking for a Growth Stock? 3 Reasons Why Neurocrine (NBIX) is a Solid Choice (Zacks)
04:05PM	Loading…
Nov-10-25 04:05PM	Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder (PR Newswire)
01:25PM	Neurocrine chalks up a depression drug failure (BioPharma Dive)
Nov-06-25 12:20PM	Earnings Estimates Rising for Neurocrine (NBIX): Will It Gain? (Zacks)
Nov-04-25 12:00PM	What Makes Neurocrine (NBIX) a New Strong Buy Stock (Zacks)
09:54AM	Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks)
Oct-30-25 04:15PM	Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings. (Investor's Business Daily)
03:21PM	Neurocrine Biosciences Inc (NBIX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
01:13PM	Earnings roundup: Alnylams down day, Neurocrines head scratch and Biogens low quality win (BioPharma Dive)
09:49AM	Alnylam Stock Has Already Doubled In 2025. But It Took A Hit On Earnings. (Investor's Business Daily)
Oct-29-25 04:14PM	Why Neurocrine Stock Was Spooked Despite Its Big Quarterly Beat (Investor's Business Daily) -6.35%
Oct-28-25 09:03PM	Neurocrine Biosciences Beats Estimates But Wall Street Punishes The Stock (24/7 Wall St.)
07:30PM	Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q3 Earnings (Zacks)
05:10PM	Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top Estimates (Zacks)
04:45PM	Neurocrine Shares Rise, But Pull Back From Steep Gains, On Strong Ingrezza Quarter (Investor's Business Daily)
04:19PM	Neurocrine Bio Surges After Crushing Third-Quarter Expectations (Investor's Business Daily)
04:06PM	Neurocrine: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Neurocrine Biosciences Reports Third Quarter 2025 Financial Results (PR Newswire)
Oct-24-25 12:00PM	Are You Looking for a Top Momentum Pick? Why Neurocrine Biosciences (NBIX) is a Great Choice (Zacks)
Oct-23-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX) (Zacks)
Oct-22-25 05:15PM	USANA Health Sciences (USNA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
10:00AM	United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-21-25 10:00AM	Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-17-25 08:30AM	Neurocrine Biosciences Presents New KINECT 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA (valbenazine) 40 mg Capsules (PR Newswire)
Oct-07-25 04:01PM	Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results (PR Newswire)
Oct-06-25 04:05PM	Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise (PR Newswire)
08:30AM	Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA (valbenazine) Capsules for Huntington's Disease Chorea (PR Newswire)
Sep-25-25 09:55AM	Should You be Optimistic on Neurocrine Biosciences (NBIX)? (Insider Monkey)
Sep-24-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
Sep-23-25 08:30AM	Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden (PR Newswire)
Sep-22-25 08:30AM	Neurocrine Biosciences Presents Positive New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder (PR Newswire)
Sep-16-25 04:05PM	Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025 (PR Newswire)
02:58PM	What Does Wall Street Think About Neurocrine Biosciences (NBIX)? (Insider Monkey)
Sep-02-25 04:03AM	Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access (Insider Monkey)
Aug-26-25 04:01PM	Neurocrine Biosciences to Present at Upcoming Investor Conferences in September (PR Newswire)
Aug-20-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
Aug-12-25 10:16AM	Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus (Zacks)
Aug-06-25 04:01PM	Neurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference (PR Newswire)
Jul-31-25 03:32AM	Neurocrine Biosciences Inc (NBIX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com) -6.24%
Jul-30-25 06:00PM	Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q2 Earnings (Zacks)
05:10PM	Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:05PM	Neurocrine: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Neurocrine Biosciences Reports Second Quarter 2025 Financial Results (PR Newswire)
Jul-28-25 11:40AM	CPRX vs. NBIX: Which Stock Should Value Investors Buy Now? (Zacks)
Jul-27-25 09:58AM	Neurocrine Biosciences Grows Pipeline While Maintaining Steady Investor Confidence (Insider Monkey)
Jul-25-25 11:28PM	Morgan Stanley Lifts PT on Neurocrine Biosciences (NBIX) to $150 From $148, Keeps Overweight Rating (Insider Monkey)
Jul-24-25 10:00AM	Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-23-25 10:00AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-15-25 10:57AM	Neurocrine shares new one-year data from trial of Crenessity for CAH (Clinical Trials Arena)
09:00AM	Neurocrine Biosciences Leverages PicnicHealth to Reveal Critical Care Gaps for Patients with Rare Genetic Condition (PR Newswire)
08:30AM	Neurocrine Biosciences Presents New Analysis of CAHtalog Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure, Suboptimal Disease Control or Both at ENDO 2025 (PR Newswire)
Jul-14-25 04:35PM	Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society's Annual Meeting (PR Newswire)
08:30AM	Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY (crinecerfont) in Adult Patients, at ENDO 2025 (PR Newswire)
Jul-10-25 11:26PM	Untapped Patient Base, Ingrezza Growth Keep Neurocrine (NBIX) on Guggenheim's Buy List (Insider Monkey)
08:00AM	Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity (Investor's Business Daily)
Jul-09-25 04:01PM	Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial Results (PR Newswire)
Jun-30-25 04:05PM	Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist (PR Newswire)
Jun-29-25 08:36AM	3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking (MarketBeat)
Jun-27-25 08:30AM	Neurocrine Biosciences Presents New Post-Hoc Data Analyses from KINECT-HD Study Demonstrating Significant Reduction in Disease Burden with INGREZZA (valbenazine) Capsules for Huntington's Disease Chorea (PR Newswire)
Jun-23-25 11:40AM	EGO or AEM: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CPRX vs. NBIX: Which Stock Is the Better Value Option? (Zacks)
Jun-20-25 08:30AM	Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA (valbenazine) Capsules in Older Adults with Tardive Dyskinesia (PR Newswire)
Jun-17-25 06:20AM	Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? (Zacks)
Jun-12-25 06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
Jun-09-25 04:05PM	Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer (PR Newswire)
Jun-03-25 11:40AM	CPRX or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
Jun-02-25 08:30AM	Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO Study Demonstrating INGREZZA (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive Dyskinesia (PR Newswire)
May-30-25 04:30PM	Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors (GlobeNewswire)
May-29-25 12:03AM	Neurocrine Biosciences, Inc. (NBIX)'s M4 Agonist Shows Promise in Schizophrenia Phase 2 Trial, Phase 3 Launched (Insider Monkey)
May-28-25 04:05PM	Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025 (PR Newswire)
May-27-25 06:20AM	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? (Zacks)

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boyer David W.	Chief Corp. Affairs Officer	Jan 31 '26	Option Exercise	0.00	2,096	0	5,902	Feb 03 06:22 PM
BENEVICH ERIC	Chief Commercial Officer	Jan 31 '26	Option Exercise	0.00	2,294	0	54,047	Feb 03 06:21 PM
ABERNETHY MATT	Chief Financial Officer	Jan 31 '26	Option Exercise	0.00	2,437	0	38,465	Feb 03 06:06 PM
Cooke Julie	Chief Human Resources Officer	Jan 31 '26	Option Exercise	0.00	1,741	0	28,599	Feb 03 06:05 PM
Delaet Ingrid	Chief Regulatory Officer	Jan 31 '26	Option Exercise	0.00	801	0	5,531	Feb 03 06:04 PM
Gano Kyle	Chief Executive Officer	Jan 31 '26	Option Exercise	0.00	2,927	0	143,334	Feb 03 06:03 PM
GORMAN KEVIN CHARLES	Director	Jan 31 '26	Option Exercise	0.00	5,142	0	519,738	Feb 03 06:02 PM
Lippoldt Darin	Chief Legal Officer	Jan 31 '26	Option Exercise	0.00	2,373	0	49,127	Feb 03 06:01 PM
Onyia Jude	Chief Scientific Officer	Jan 31 '26	Option Exercise	0.00	238	0	16,119	Feb 03 06:01 PM
Gano Kyle	Chief Executive Officer	Jan 16 '26	Option Exercise	35.99	36,400	1,310,036	174,995	Jan 20 06:56 PM
Gano Kyle	Chief Executive Officer	Jan 16 '26	Sale	132.70	36,400	4,830,458	140,407	Jan 20 06:56 PM
KYLE GANO	Officer	Jan 16 '26	Proposed Sale	133.35	36,400	4,853,940		Jan 16 04:21 PM
Lippoldt Darin	Chief Legal Officer	Jan 08 '26	Option Exercise	35.99	3,349	120,531	46,754	Jan 12 04:18 PM
Norwalk Leslie V	Director	Dec 15 '25	Option Exercise	91.07	10,000	910,742	12,429	Dec 17 04:24 PM
Norwalk Leslie V	Director	Dec 15 '25	Sale	152.23	5,000	761,144	7,429	Dec 17 04:24 PM
Norwalk Leslie V	Director	Dec 16 '25	Sale	155.09	1,190	184,558	6,239	Dec 17 04:24 PM
Norwalk Leslie V	Director	Dec 15 '25	Proposed Sale	155.11	11,250	1,745,000		Dec 15 10:58 AM
Lippoldt Darin	Chief Legal Officer	Dec 08 '25	Option Exercise	43.24	4,376	189,218	47,781	Dec 10 09:04 AM
Lippoldt Darin	Chief Legal Officer	Dec 08 '25	Sale	159.65	4,376	698,615	43,405	Dec 10 09:04 AM
DARIN LIPPOLDT	Officer	Dec 08 '25	Proposed Sale	155.51	4,376	680,512		Dec 08 04:35 PM
LYONS GARY A	Director	Dec 03 '25	Option Exercise	47.89	15,000	718,350	135,482	Dec 04 04:14 PM
LYONS GARY A	Director	Dec 03 '25	Sale	152.61	15,000	2,289,082	120,482	Dec 04 04:14 PM
GARY A LYONS REVOCABLE LIVING	Director	Dec 03 '25	Proposed Sale	152.48	15,000	2,287,200		Dec 03 04:36 PM
BENEVICH ERIC	Chief Commercial Officer	Nov 28 '25	Option Exercise	35.99	5,970	214,860	50,863	Dec 02 05:21 PM
BENEVICH ERIC	Chief Commercial Officer	Nov 28 '25	Sale	151.74	5,970	905,881	44,893	Dec 02 05:21 PM
Onyia Jude	Chief Scientific Officer	Nov 29 '25	Option Exercise	0.00	4,426	0	18,129	Dec 02 05:14 PM
ERIC BENEVICH	Officer	Nov 28 '25	Proposed Sale	151.58	5,970	904,933		Nov 28 01:20 PM
MORROW GEORGE J	Director	Nov 25 '25	Option Exercise	47.89	15,000	718,350	22,068	Nov 26 04:28 PM
MORROW GEORGE J	Director	Nov 25 '25	Sale	143.37	15,000	2,150,512	7,068	Nov 26 04:28 PM
GEORGE MORROW	Director	Nov 25 '25	Proposed Sale	141.25	15,000	2,118,750		Nov 25 04:25 PM
RASTETTER WILLIAM H	Director	Nov 05 '25	Option Exercise	47.89	18,000	862,020	58,360	Nov 06 05:25 PM
RASTETTER WILLIAM H	Director	Nov 05 '25	Sale	151.82	18,000	2,732,690	40,360	Nov 06 05:25 PM
Gano Kyle	Officer	Nov 04 '25	Proposed Sale	141.97	300	42,591		Nov 05 09:09 PM
WILLIAM H. RASTETTER	Director	Nov 05 '25	Proposed Sale	143.19	18,000	2,577,420		Nov 05 04:19 PM
Gano Kyle	Chief Executive Officer	Nov 01 '25	Option Exercise	0.00	613	0	140,720	Nov 04 08:18 PM
Gano Kyle	Chief Executive Officer	Nov 04 '25	Sale	141.97	300	42,591	140,407	Nov 04 08:18 PM
GORMAN KEVIN CHARLES	Director	Aug 07 '25	Option Exercise	35.99	106,322	3,826,529	620,918	Aug 11 04:55 PM
GORMAN KEVIN CHARLES	Director	Aug 07 '25	Sale	126.41	106,322	13,440,281	514,596	Aug 11 04:55 PM
KEVIN CHARLES GORMAN	Director	Aug 07 '25	Proposed Sale	128.43	106,322	13,654,934		Aug 07 04:24 PM
Delaet Ingrid	Chief Regulatory Officer	Jul 10 '25	Option Exercise	79.02	457	36,112	5,187	Jul 11 05:15 PM
Delaet Ingrid	Chief Regulatory Officer	Jul 10 '25	Sale	135.00	457	61,695	4,730	Jul 11 05:15 PM
Onyia Jude	Chief Scientific Officer	Jul 09 '25	Option Exercise	84.74	59,819	5,069,062	78,108	Jul 11 05:01 PM
Onyia Jude	Chief Scientific Officer	Jul 09 '25	Sale	130.46	59,819	7,803,688	18,289	Jul 11 05:01 PM
INGRID DELAET	Officer	Jul 10 '25	Proposed Sale	133.51	457	61,014		Jul 10 04:32 PM
Onyia Jude	Chief Scientific Officer	Jul 02 '25	Option Exercise	84.74	20,362	1,725,476	38,651	Jul 07 04:10 PM
Onyia Jude	Chief Scientific Officer	Jul 02 '25	Sale	130.13	20,362	2,649,738	18,289	Jul 07 04:10 PM
JUDE ONYIA	Officer	Jul 02 '25	Proposed Sale	128.00	80,181	10,263,168		Jul 02 04:22 PM
GORMAN KEVIN CHARLES	Director	May 27 '25	Sale	120.38	9,613	1,157,211	514,596	May 29 06:15 PM
KEVIN CHARLES GORMAN	Director	May 27 '25	Proposed Sale	120.18	9,613	1,155,290		May 27 04:38 PM
RASTETTER WILLIAM H	Director	May 22 '25	Option Exercise	0.00	2,869	0	40,360	May 22 06:15 PM
POON CHRISTINE A	Director	May 22 '25	Option Exercise	0.00	1,435	0	1,435	May 22 05:32 PM
Sharp Shalini	Director	May 22 '25	Option Exercise	0.00	1,435	0	2,429	May 22 05:28 PM
SHERWIN STEPHEN A	Director	May 22 '25	Option Exercise	0.00	2,869	0	13,542	May 22 05:26 PM
POPS RICHARD F	Director	May 22 '25	Option Exercise	0.00	2,869	0	34,480	May 22 05:23 PM
MORROW GEORGE J	Director	May 22 '25	Option Exercise	0.00	2,869	0	7,068	May 22 05:20 PM
LYONS GARY A	Director	May 22 '25	Option Exercise	0.00	1,435	0	120,482	May 22 05:18 PM
Norwalk Leslie V	Director	May 22 '25	Option Exercise	0.00	1,435	0	2,429	May 22 05:14 PM
Mercier Johanna	Director	May 22 '25	Option Exercise	0.00	1,435	0	3,535	May 22 05:12 PM
Cooke Julie	Chief Human Resources Officer	May 16 '25	Option Exercise	61.82	6,468	399,852	26,858	May 20 04:43 PM
RASTETTER WILLIAM H	Director	May 05 '25	Option Exercise	42.76	30,000	1,282,800	67,491	May 07 07:05 PM
RASTETTER WILLIAM H	Director	May 05 '25	Sale	110.20	30,000	3,305,952	37,491	May 07 07:05 PM
WILLIAM H. RASTETTER	Officer	May 05 '25	Proposed Sale	109.68	30,000	3,290,400		May 05 04:40 PM

Open in Screener

SLGN

Silgan Holdings Inc

Feb 17 • 10:37AM ET

48.44

-0.21 -0.43 %

Consumer Cyclical • Packaging & Containers • USA • NYSE

SLGN Silgan Holdings Inc daily Stock Chart

Peers: CCK SON OI GPK PKG SEE IP AVY BERY MYE

| Held by: IJH VTI VB VBR VXF SDY MDY REGL DFAT IJJ

Index	-	P/E	17.99	EPS (ttm)	2.69	Insider Own	16.65%	Shs Outstand	105.67M	Perf Week	-0.49%
Market Cap	5.12B	Forward P/E	11.84	EPS next Y	4.09	Insider Trans	-0.02%	Shs Float	87.91M	Perf Month	13.31%
Enterprise Value	8.38B	PEG	2.06	EPS next Q	0.75	Inst Own	86.64%	Short Float	9.18%	Perf Quarter	25.85%
Income	288.40M	P/S	0.79	EPS this Y	2.28%	Inst Trans	7.26%	Short Ratio	7.99	Perf Half Y	4.22%
Sales	6.48B	P/B	2.25	EPS next Y	7.51%	ROA	3.21%	Short Interest	8.07M	Perf YTD	19.99%
Book/sh	21.51	P/C	4.74	EPS next 5Y	5.76%	ROE	13.53%	52W High	57.04 -15.08%	Perf Year	-9.76%
Cash/sh	10.23	P/FCF	12.11	EPS past 3/5Y	-4.19% -0.52%	ROIC	4.36%	52W Low	36.15 34.00%	Perf 3Y	-9.86%
Dividend Est.	0.82 (1.69%)	EV/EBITDA	8.59	Sales past 3/5Y	0.37% 5.66%	Gross Margin	21.40%	Volatility	1.79% 2.19%	Perf 5Y	26.71%
Dividend TTM	0.80 (1.65%)	EV/Sales	1.29	EPS Y/Y TTM	4.38%	Oper. Margin	10.14%	ATR (14)	1.02	Perf 10Y	88.04%
Dividend Ex-Date	Dec 01, 2025	Quick Ratio	1.05	Sales Y/Y TTM	10.73%	Profit Margin	4.45%	RSI (14)	74.94	Recom	1.54
Dividend Gr. 3/5Y	7.72% 10.76%	Current Ratio	1.64	EPS Q/Q	-59.55%	SMA20	6.48%	Beta	0.68	Target Price	55.27
Payout	29.63%	Debt/Eq	1.91	Sales Q/Q	4.07%	SMA50	13.41%	Rel Volume	0.59	Prev Close	48.65
Employees	17315	LT Debt/Eq	1.91	Earnings	Feb 04 BMO	SMA200	4.16%	Avg Volume	1.01M	Price	48.44
IPO	Feb 14, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.31% 0.65%	Trades		Volume	126,868	Change	-0.43%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-15-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$43
Nov-24-25	Initiated	UBS	Neutral	$42
Oct-17-25	Downgrade	Raymond James	Strong Buy → Outperform	$53
Aug-28-25	Upgrade	BofA Securities	Neutral → Buy	$57
Jul-09-25	Downgrade	BofA Securities	Buy → Neutral	$59
May-01-25	Upgrade	JP Morgan	Neutral → Overweight	$57
Apr-22-25	Upgrade	Raymond James	Outperform → Strong Buy	$65 → $60
Aug-01-24	Upgrade	JP Morgan	Underweight → Neutral	$46 → $53
Jul-08-24	Upgrade	Citigroup	Neutral → Buy	$50
Jan-03-24	Downgrade	Citigroup	Buy → Neutral	$44 → $47
Oct-20-23	Resumed	Raymond James	Outperform	$50 → $55
Jul-27-23	Upgrade	Robert W. Baird	Neutral → Outperform	$53
Apr-27-23	Upgrade	Citigroup	Neutral → Buy	$56
Jan-05-23	Upgrade	Truist	Hold → Buy	$64
Nov-24-21	Initiated	Raymond James	Outperform	$47
Oct-06-21	Initiated	Loop Capital	Buy	$62
Oct-01-21	Downgrade	JP Morgan	Neutral → Underweight	$40
Sep-14-21	Initiated	Truist	Hold	$46
May-20-21	Initiated	Longbow	Buy	$58
Jan-28-21	Upgrade	BofA Securities	Underperform → Buy	$50

Show Previous Ratings

Feb-11-26 12:41AM	5 Revealing Analyst Questions From Silgan Holdings's Q4 Earnings Call (StockStory)
Feb-05-26 05:06AM	Silgan Q4 Earnings Call Highlights (MarketBeat)
12:44AM	SLGN Q4 Deep Dive: Dispensing Growth, Integration Synergies, and Stable Margin Outlook (StockStory)
Feb-04-26 04:04PM	Silgan Holdings Inc (SLGN) Q4 2025 Earnings Call Highlights: Record Cash Flow and Strategic ... (GuruFocus.com) +9.62%
12:25PM	Why Silgan Holdings (SLGN) Stock Is Trading Up Today (StockStory)
10:53AM	Loading…
10:53AM	Avery Dennison Earnings Beat Estimates in Q4, Revenues Rise Y/Y (Zacks)
10:16AM	Silgan (SLGN) Q4 2025 Earnings Call Transcript (Motley Fool)
09:30AM	Silgan (SLGN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:05AM	Silgan Holdings (SLGN) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:12AM	Silgan Holdings's (NYSE:SLGN) Q4 CY2025 Sales Top Estimates (StockStory)
05:48AM	Silgan: Q4 Earnings Snapshot (Associated Press Finance)
05:30AM	Silgan Announces Fourth Quarter and Full Year 2025 Results; Expects Continued Growth in 2026 (Business Wire)
Feb-03-26 01:28PM	Bernzott Capital Buys Another $3 Million of Silgan Stock Amid 20% Dip (Motley Fool)
12:03PM	BALL's Q4 Earnings Beat Estimates, Sales Up Y/Y on Higher Volumes (Zacks)
Feb-02-26 10:15PM	Silgan Holdings Earnings: What To Look For From SLGN (StockStory)
07:50AM	Loading…
Jan-29-26 07:50AM	Xerox Holdings Corporation (XRX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Jan-28-26 12:29PM	Packaging Corp Earnings Miss Estimates in Q4, Sales Increase Y/Y (Zacks)
10:00AM	Earnings Preview: Silgan Holdings (SLGN) Q4 Earnings Expected to Decline (Zacks)
Jan-19-26 11:31PM	2 Value Stocks with Promising Prospects and 1 Facing Challenges (StockStory)
Jan-16-26 04:15PM	Silgan to Release Fourth Quarter and Full Year 2025 Earnings Results on February 4, 2026 (Business Wire)
Jan-15-26 02:18AM	Truist Sees Soft Early-2026 Packaging Volumes, but Keeps Bullish View on Silgan (SLGN) (Insider Monkey)
Jan-05-26 11:04PM	3 Reasons to Sell SLGN and 1 Stock to Buy Instead (StockStory)
Jan-01-26 10:32PM	A Look Back at Industrial Packaging Stocks' Q3 Earnings: Silgan Holdings (NYSE:SLGN) Vs The Rest Of The Pack (StockStory)
Dec-22-25 09:18AM	Implied Volatility Surging for Silgan Holdings Stock Options (Zacks)
Dec-08-25 04:51PM	Silgan Holdings Inc. (SLGN): A Bull Case Theory (Insider Monkey)
Nov-28-25 11:30AM	Why Is Silgan (SLGN) Up 3.4% Since Last Earnings Report? (Zacks)
Nov-11-25 02:41PM	1 of Wall Street's Favorite Stock to Own for Decades and 2 We Question (StockStory)
Nov-06-25 08:00AM	Take a Drink From This Can-Do Stock. Shares Could Pop 30%. (Barrons.com)
Nov-05-25 06:55AM	Silgan Announces New Authorization for Stock Repurchases (Business Wire)
12:40AM	The Top 5 Analyst Questions From Silgan Holdings's Q3 Earnings Call (StockStory)
04:30PM	Loading…
Nov-04-25 04:30PM	Silgan Declares Quarterly Dividend (Business Wire)
01:12PM	BALL's Q3 Earnings Match Estimates, Sales Up Y/Y on Higher Volumes (Zacks)
Oct-31-25 01:40PM	Silgan Beats Q3 Earnings Estimates, Trims '25 Outlook on Low Volumes (Zacks)
Oct-30-25 03:53PM	Silgan Holdings Inc (SLGN) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Market ... (GuruFocus.com)
11:31AM	Silgan Holdings (SLGN) Drops to New Low on Dismal Growth Outlook (Insider Monkey)
01:35AM	SLGN Q3 Deep Dive: Guidance Cut as Consumer Bifurcation, Inventory Actions Shape Outlook (StockStory)
Oct-29-25 07:36PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research) -13.57%
06:32PM	Why Silgan Holdings Stock Dove by Nearly 14% on Wednesday (Motley Fool)
04:19PM	Box Demand Drop Stings Packaging Firms (The Wall Street Journal)
01:11PM	Why Silgan Holdings (SLGN) Shares Are Getting Obliterated Today (StockStory)
08:05AM	Silgan Holdings (SLGN) Q3 Earnings and Revenues Top Estimates (Zacks)
07:15AM	Silgan Holdings's (NYSE:SLGN) Q3: Beats On Revenue But Stock Drops 10.6% (StockStory)
07:04AM	Silgan: Q3 Earnings Snapshot (Associated Press Finance)
06:55AM	Silgan Announces Third Quarter 2025 Results (Business Wire)
Oct-28-25 09:32AM	Silgan Holdings Inc (SLGN) Q3 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-27-25 11:11PM	Silgan Holdings (SLGN) Q3 Earnings Report Preview: What To Look For (StockStory)
Oct-22-25 12:43PM	Avery Dennison Q3 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
10:38AM	Analyst Report: Silgan Holdings Inc. (Morningstar Research)
10:00AM	Silgan Holdings (SLGN) Reports Next Week: What You Should Expect (Zacks)
Oct-20-25 05:15PM	Crown Holdings (CCK) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Oct-17-25 09:36AM	Deere upgraded, AST SpaceMobile downgraded: Wall Street's top analyst calls (The Fly)
Oct-10-25 04:10PM	Silgan to Release Third Quarter 2025 Earnings Results on October 29, 2025 (Business Wire)
Sep-25-25 12:04AM	3 Reasons SLGN is Risky and 1 Stock to Buy Instead (StockStory)
Sep-11-25 06:04AM	Bank of America Says $7 Trillion Boost Could Drive Year-End Rally Here Are 2 Stocks That Could Jump (TipRanks)
Sep-03-25 04:30PM	Silgan Announces Pricing of New Senior Notes Offering (Business Wire)
07:05AM	Silgan Announces New Senior Notes Offering (Business Wire)
Aug-28-25 11:32PM	Q2 Earnings Highlights: Silgan Holdings (NYSE:SLGN) Vs The Rest Of The Industrial Packaging Stocks (StockStory)
09:39AM	Five Below upgraded, Bill downgraded: Wall Street's top analyst calls (The Fly)
09:38AM	BofA upgrades Silgan and International Paper, lifts containerboard price forecasts (Investing.com)
Aug-27-25 11:33PM	Q2 Rundown: Silgan Holdings (NYSE:SLGN) Vs Other Industrial Packaging Stocks (StockStory)
Aug-13-25 12:14AM	Silgan Holdings's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
12:11AM	SLGN Q2 Deep Dive: Guidance Cut Amid Customer Bankruptcy and Weather-Driven Volume Headwinds (StockStory)
Aug-05-25 04:35PM	Silgan Declares Quarterly Dividend (Business Wire)
12:56PM	Ball Corp Earnings Surpass Estimates in Q2, Sales Increase Y/Y (Zacks)
Jul-31-25 07:39AM	Silgan Holdings (SLGN) Dives 15% on Lower Growth Outlook (Insider Monkey)
04:12AM	Analyst Report: Silgan Holdings Inc. (Morningstar Research)
Jul-30-25 01:41PM	Why Silgan Holdings (SLGN) Shares Are Falling Today (StockStory) -15.23%
08:05AM	Silgan Holdings (SLGN) Q2 Earnings Lag Estimates (Zacks)
07:14AM	Silgan Holdings's (NYSE:SLGN) Q2 Sales Beat Estimates (StockStory)
07:02AM	Silgan: Q2 Earnings Snapshot (Associated Press Finance)
06:55AM	Silgan Announces Second Quarter 2025 Results (Business Wire)
Jul-29-25 09:28AM	Silgan Holdings Inc (SLGN) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-28-25 11:17PM	What To Expect From Silgan Holdings's (SLGN) Q2 Earnings (StockStory)
Jul-24-25 01:22PM	Packaging Corp Earnings Surpass Estimates in Q2, Sales Rise Y/Y (Zacks)
09:21AM	What To Expect From Silgan Holdings Inc (SLGN) Q2 2025 Earnings (GuruFocus.com)
12:36AM	3 Low-Volatility Stocks with Questionable Fundamentals (StockStory)
Jul-23-25 10:00AM	Silgan Holdings (SLGN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-22-25 11:38AM	Crown Holdings Q2 Earnings & Revenues Beat Estimates, '25 View Raised (Zacks)
10:10AM	Avery Dennison Q2 Earnings Beat Estimates, Revenues Dip Y/Y (Zacks)
Jul-11-25 04:15PM	Silgan to Release Second Quarter 2025 Earnings Results on July 30, 2025 (Business Wire)
Jul-06-25 11:35PM	Reflecting On Industrial Packaging Stocks' Q1 Earnings: Silgan Holdings (NYSE:SLGN) (StockStory)
Jul-02-25 12:06AM	3 Reasons to Avoid SLGN and 1 Stock to Buy Instead (StockStory)
Jun-25-25 07:41AM	5 Insightful Analyst Questions From Silgan Holdings's Q1 Earnings Call (StockStory)
Jun-11-25 05:06PM	Is Consumer Discretionary a Dead End? These 3 Stocks Say No (MarketBeat)
May-30-25 11:31AM	Why Is Silgan (SLGN) Up 4.5% Since Last Earnings Report? (Zacks)
May-08-25 12:32AM	3 Profitable Stocks in Hot Water (StockStory)
May-07-25 04:26PM	Silgan Holdings Inc. (SLGN): Among the Best Mid-Cap Dividend Aristocrats to Invest in Now (Insider Monkey)
May-06-25 04:05PM	Silgan Declares Quarterly Dividend (Business Wire)
12:33PM	Ball Corp Earnings Surpass Estimates in Q1, Sales Increase Y/Y (Zacks)
12:32PM	Silgan Holdings Q1 Earnings Surpass Estimates, Shares Rise 4% (Zacks)
May-02-25 08:29PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research)
May-01-25 12:39PM	Amcor Meets Earnings Estimates in Q3, Closes Berry Global Merger (Zacks)
08:19AM	Analyst Report: Silgan Holdings Inc. (Morningstar Research)
Apr-30-25 05:36PM	Silgan Holdings Inc. (SLGN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
02:58PM	Crown Holdings Stock Sees Relative Strength Rating Rise To 86 (Investor's Business Daily)
12:50PM	O-I Glass Q1 Earnings & Revenues Beat Estimates on Higher Volumes (Zacks)
12:25PM	CCK Beats Q1 Earnings on Higher Volumes, Raises 2025 Guidance (Zacks)
08:05AM	Silgan Holdings (SLGN) Surpasses Q1 Earnings Estimates (Zacks)
06:55AM	Silgan Announces Record First Quarter 2025 Results; Confirms 2025 Earnings and Free Cash Flow Estimates (Business Wire)
Apr-29-25 03:04AM	Silgan Holdings (SLGN) Reports Earnings Tomorrow: What To Expect (StockStory)

Silgan Holdings, Inc. engages in the manufacture and sale of rigid packaging solutions. It operates through the following business segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers. The Dispensing and Specialty Closures segment involves the manufacture and sale of finishes. The Metal Containers segment includes steel and aluminum vessels. The Custom Containers segment refers to designed plastic canister. The company was founded by R. Philip Silver and D. Greg Horrigan in 1987 and is headquartered in Norwalk, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ulmer Kimberly Irene	SVP & Chief Accounting Officer	Nov 07 '25	Buy	38.11	1,000	38,110	105,321	Nov 10 04:31 PM
Greenlee Adam J	President and CEO	Oct 31 '25	Buy	38.19	7,000	267,298	328,164	Nov 03 08:30 AM
LEWIS ROBERT B	EVP, Corp. Dev. & Admin.	Aug 22 '25	Sale	46.70	11,000	513,700	142,378	Aug 22 04:31 PM
Lewis Robert B	Officer	Aug 21 '25	Proposed Sale	45.61	11,000	501,710		Aug 20 04:31 PM
LEWIS ROBERT B	EVP, Corp. Dev. & Admin.	May 19 '25	Sale	55.92	10,000	559,206	153,378	May 21 04:30 PM
ALLOTT ANTHONY J	Director	May 16 '25	Sale	55.22	81,152	4,480,889	367,511	May 20 04:32 PM
LEWIS ROBERT B	Officer	May 19 '25	Proposed Sale	54.88	10,000	548,800		May 16 04:42 PM
ALLOTT ANTHONY J	Director	May 15 '25	Proposed Sale	54.57	81,152	4,428,465		May 14 04:32 PM
Prinzen B Frederik	Sr. V.P. - Corp. Dev.	May 06 '25	Sale	54.05	2,378	128,531	1,380	May 08 04:20 PM
Prinzen B Frederik	Officer	May 06 '25	Proposed Sale	54.85	2,378	130,433		May 05 04:38 PM
Greenlee Adam J	President and CEO	Feb 24 '25	Sale	54.73	125,000	6,840,762	227,332	Feb 26 04:32 PM
Greenlee Adam J	Officer	Feb 24 '25	Proposed Sale	54.40	125,000	6,800,000		Feb 21 05:13 PM

KOS

Kosmos Energy Ltd

NBIX

Neurocrine Biosciences, Inc

SLGN

Silgan Holdings Inc

Upgrade your FINVIZ experience